CryoVera is a biotech startup developing extremophile-inspired antifreeze molecules to prevent ice recrystallization in frozen foods, helping manufacturers preserve product texture, improve shelf life, and reduce waste in the cold chain.
CryoVera is a Paris-based biotechnology startup developing antifreeze ingredients designed to prevent ice recrystallization in frozen foods. The company's technology is inspired by extremophile organisms that survive in extreme cold, utilizing molecules that bind to ice crystals to inhibit them from growing or aggregating into larger, texture-damaging structures. CryoVera employs a clean extraction process, which may be supported by microbial enzymes, to isolate these functional molecules from abundant natural sources. By preventing the formation of icy, gritty, or crunchy textures, the technology aims to preserve the quality and sensory profile of frozen products throughout the cold chain.
This innovation addresses a significant challenge for food manufacturers who struggle with texture degradation and quality loss during the storage and distribution of frozen goods. By providing an effective stabilizer that functions at low inclusion levels, CryoVera offers a cost-effective solution for improving product quality, extending shelf life, and reducing food waste. The company is currently engaging with manufacturers across various categories, including ice cream, frozen bakery, seafood, and plant-based meat, to sample its tailored formulations and demonstrate the efficacy of its anti-crystallization technology. CryoVera is supported by investors such as Big Idea Ventures and is focused on building a scalable, regulatory-compliant approach to market.